MT-TS2
Basic information
Region (hg38): M:12207-12265
Previous symbols: [ "MTTS2" ]
Links
Phenotypes
GenCC
Source:
- mitochondrial disease (Moderate), mode of inheritance: Mitochondrial
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) | Maternal | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Gastrointestinal; Neurologic | 16950817 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MT-TS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 0 | 0 | 0 |
Variants in MT-TS2
This is a list of pathogenic ClinVar variants found in the MT-TS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
M-12213-G-A | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | ||
M-12215-T-C | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12216-C-T | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12217-A-G | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke • Mitochondrial disease | Uncertain significance (Aug 22, 2023) | ||
M-12218-C-A | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | ||
M-12223-A-G | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12230-A-G | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | ||
M-12231-C-T | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | ||
M-12234-A-G | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12235-T-C | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12236-G-A | not specified • Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Conflicting classifications of pathogenicity (Jul 12, 2019) | ||
M-12236-GC-G | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke • See cases • Mitochondrial disease | Uncertain significance (Aug 22, 2023) | ||
M-12236-G-GC | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | ||
M-12237-C-T | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12239-C-T | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke • Mitochondrial disease | Benign (Jan 10, 2022) | ||
M-12245-T-C | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12246-C-A | not specified | Uncertain significance (May 04, 2022) | ||
M-12246-C-T | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12247-T-C | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | ||
M-12248-A-G | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | ||
M-12250-C-T | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | ||
M-12255-T-C | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | ||
M-12258-C-A | Cerebellar ataxia, cataract, and diabetes mellitus • Retinitis pigmentosa-deafness syndrome • Mitochondrial disease | Likely pathogenic (Mar 28, 2023) | ||
M-12258-C-T | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic/Likely pathogenic (May 04, 2022) | ||
M-12264-C-T | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic/Likely pathogenic (May 04, 2022) |
GnomAD
Source:
dbNSFP
Source:
- Pathway
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
(Consensus)
Mouse Genome Informatics
- Gene name
- mt-Ts2
- Phenotype